Congratulations! Bethlehem’s OraSure Technologies Inc. received nearly $630,000 to help develop an oral test for coronavirus antibodies.
The funds come from a contract with the federal Biomedical Advanced Research and Development Authority to develop an enzyme-linked immunosorbent Assay, or ELISA, which can be used for the detection of human anti-SARS-CoV-2 antibodies in oral fluid specimens. There currently are no oral fluid-based COVID antibody tests of the sort. The product is expected to increase laboratory COVID-19 antibody testing capacity. For complete details […more]